2023-09-01 2024-08-31 false Capium Accounts Production 1.1 10912319 2023-09-01 2024-08-31 10912319 bus:AbridgedAccounts 2023-09-01 2024-08-31 10912319 bus:FRS102 2023-09-01 2024-08-31 10912319 bus:AuditExemptWithAccountantsReport 2023-09-01 2024-08-31 10912319 bus:SmallCompaniesRegimeForAccounts 2023-09-01 2024-08-31 10912319 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 10912319 2023-09-01 2024-08-31 10912319 2024-08-31 10912319 bus:RegisteredOffice 2023-09-01 2024-08-31 10912319 core:WithinOneYear 2024-08-31 10912319 core:AfterOneYear 2024-08-31 10912319 1 2023-09-01 2024-08-31 10912319 bus:Director1 2023-09-01 2024-08-31 10912319 bus:Director1 2024-08-31 10912319 bus:Director1 2022-09-01 2023-08-31 10912319 2022-09-01 10912319 bus:LeadAgentIfApplicable 2023-09-01 2024-08-31 10912319 2022-09-01 2023-08-31 10912319 2023-08-31 10912319 core:WithinOneYear 2023-08-31 10912319 core:AfterOneYear 2023-08-31 10912319 bus:EntityAccountantsOrAuditors 2022-09-01 2023-08-31 10912319 bus:OrdinaryShareClass1 2023-09-01 2024-08-31 10912319 bus:OrdinaryShareClass1 2024-08-31 10912319 bus:OrdinaryShareClass1 2022-09-01 2023-08-31 10912319 bus:OrdinaryShareClass1 2023-08-31 10912319 core:CostValuation core:Non-currentFinancialInstruments 2024-08-31 10912319 core:CostValuation core:Non-currentFinancialInstruments 2023-08-31 10912319 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-08-31 10912319 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-08-31 10912319 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-08-31 10912319 core:Non-currentFinancialInstruments 2024-08-31 10912319 core:Non-currentFinancialInstruments 2023-08-31 10912319 core:ShareCapital 2024-08-31 10912319 core:ShareCapital 2023-08-31 10912319 core:RetainedEarningsAccumulatedLosses 2024-08-31 10912319 core:RetainedEarningsAccumulatedLosses 2023-08-31 10912319 dpl:Item1 2023-09-01 10912319 dpl:Item1 2024-08-31 10912319 dpl:Item1 2022-09-01 10912319 dpl:Item1 2023-08-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10912319
England and Wales

 

 

 

PHARMESSA LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 September 2023

End date: 31 August 2024
 
 
Notes
 
2024
£
  2023
£
Current assets      
Debtors 105,680    99,620 
Cash at bank and in hand 38,932    35,197 
144,612    134,817 
Creditors: amount falling due within one year (8,501)   (20,300)
Net current assets 136,111    114,517 
 
Total assets less current liabilities 136,111    114,517 
Creditors: amount falling due after more than one year (30,349)  
Net assets 105,762    114,517 
 

Capital and reserves
     
Called up share capital 3 100    100 
Profit and loss account 105,662    114,417 
Shareholders' funds 105,762    114,517 
 


For the year ended 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 21 May 2025 and were signed by:


-------------------------------
Mr Huzaifah Essa
Director
1
General Information
Pharmessa Limited is a private company, limited by shares, registered in England and Wales, registration number 10912319, registration address Arden, Station Lane, Preston, Lancashire, PR3 5DX.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
2.

Average number of employees

Average number of employees during the year was 1 (2023 : 1).
3.

Share Capital

Authorised
100 Class A shares of £1.00 each
Allotted, called up and fully paid
2024
£
  2023
£
100 Class A shares of £1.00 each 100    100 
100    100 

2